Novel triazole-tetrahydroisoquinoline hybrids as human aromatase inhibitors
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 93, 103327
Abstract
No abstract availableKeywords
Funding Information
- Srinakharinwirot University
This publication has 43 references indexed in Scilit:
- Aromatase inhibition 2013: clinical state of the art and questions that remain to be solvedEndocrine-Related Cancer, 2013
- Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysisJNCI: Journal of the National Cancer Institute, 2011
- Gold nanoparticles supported on TiO 2 catalyse the cycloisomerisation/oxidative dimerisation of aryl propargyl ethersChemical Communications, 2010
- Diazo Transfer−Click Reaction Route to New, Lipophilic Teicoplanin and Ristocetin Aglycon Derivatives with High Antibacterial and Anti-influenza Virus Activity: An Aggregation and Receptor Binding StudyJournal of Medicinal Chemistry, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Steroid Hormone Transforming Aldo‐Keto Reductases and CancerAnnals of the New York Academy of Sciences, 2009
- Validation of Molecular Docking Programs for Virtual Screening against Dihydropteroate SynthaseJournal of Chemical Information and Modeling, 2009
- Structural basis for androgen specificity and oestrogen synthesis in human aromataseNature, 2009
- Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98Journal of Clinical Oncology, 2007
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004